← Back to Clinical Trials
Recruiting NCT06137521
NCT06137521 Risk Factors and Outcomes in Coronary Chronic Total Occlusion
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06137521 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ruijin Hospital |
| Condition | Chronic Total Occlusion |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2010-01-01 |
| Primary Completion | 2026-12-31 |
Trial Parameters
Condition Chronic Total Occlusion
Sponsor Ruijin Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 3,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2010-01-01
Completion 2026-12-31
All Conditions
Interventions
Coronary angiography
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This study aims to assess the risk factors and evaluate the long-term outcomes of patients with coronary chronic total occlusion (CTO) treated with percutaneous coronary intervention or medical treatment.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years; Patients with angina or silent ischemia and documented ischemia; Patients with CTO ≥ 3months Exclusion Criteria: * eGFR\<15mL/(min·1.73m2); Chronic heart failure with NYHA grade ≥3; Had a history of coronary artery bypass grafting; Had received a percutaneous coronary intervention within the prior 3 months; Malignant tumor or immune system disorders; Pulmonary heart disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology